Pregabalin Fails to Improve Diabetic, HIV Neuropathy - Medscape
EON: Enhanced Online News (press release)Pregabalin Fails to Improve Diabetic, HIV NeuropathyMedscapeMay 8, 2012 — A phase 3 clinical trial of pregabalin (Lyrica, Pfizer) failed to meet its primary endpoint of improvement in mean pain scores relative to baseline in patients with inadequately treated painful diabetic neuropathy, the company announced.
Pfizer Stops Phase 3 Trial Of Lyrica (pregabalin) Capsules CV In Neuropathic ... - MarketWatch (press release)
Fox11online.
Pregabalin Treats Neuropathic Pain in Spinal Cord Injury - Medscape
Pregabalin Treats Neuropathic Pain in Spinal Cord InjuryMedscapeMay 2, 2012 (New Orleans, Louisiana) — New research shows that the anticonvulsant drug pregabalin (Lyrica, Pfizer) provides rapid and sustained relief from pain and pain-related sleep disturbance in patients with spinal cord injuries (SCIs).
Long-term Efficacy of Pregabalin Trumps Pramipexole for RLS - Medscape
Long-term Efficacy of Pregabalin Trumps Pramipexole for RLSMedscapeMay 2, 2012 (New Orleans, Louisiana) — The alpha-2-delta ligand pregabalin is more effective and has less augmentation than the dopamine agonist pramipexole for the long-term treatment of restless legs syndrome (RLS), new research shows.
New Lyrica Oral Formulation For Patients With Dysphagia Available In UK - Medical News Today
New Lyrica Oral Formulation For Patients With Dysphagia Available In UKMedical News TodayLyrica® (pregabalin) is now available in a new strawberry-flavored oral solution form in the UK, in order to benefit patients who have difficulty in taking medication in capsule form or for those with dysphagia (swallowing difficulty).